RENULYS Trademark

Trademark Overview


On Wednesday, August 4, 2021, a trademark application was filed for RENULYS with the United States Patent and Trademark Office. The USPTO has given the RENULYS trademark a serial number of 90864384. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, June 28, 2024. This trademark is owned by Pfizer Inc.. The RENULYS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of vaso-occlusive crisis; pharmaceutical preparations for the treatment of sickle cell disease
renulys

General Information


Serial Number90864384
Word MarkRENULYS
Filing DateWednesday, August 4, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, June 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of vaso-occlusive crisis; pharmaceutical preparations for the treatment of sickle cell disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Saturday, August 7, 2021NEW APPLICATION ENTERED
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 2, 2022ASSIGNED TO EXAMINER
Monday, May 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 5, 2023SOU TEAS EXTENSION RECEIVED
Thursday, January 5, 2023SOU EXTENSION 1 FILED
Thursday, January 5, 2023SOU EXTENSION 1 GRANTED
Monday, March 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 10, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 10, 2023SOU EXTENSION 2 FILED
Monday, July 10, 2023SOU EXTENSION 2 GRANTED
Wednesday, July 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 21, 2023SOU TEAS EXTENSION RECEIVED
Saturday, January 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 21, 2023SOU EXTENSION 3 FILED
Thursday, December 21, 2023SOU EXTENSION 3 GRANTED
Wednesday, May 1, 2024ASSIGNED TO EXAMINER
Friday, June 28, 2024SOU EXTENSION 4 FILED
Saturday, December 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 28, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 28, 2024SOU EXTENSION 4 GRANTED
Friday, June 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED